Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Lowers Price Target to $23

Author: Benzinga Newsdesk | July 26, 2024 02:14pm
JMP Securities analyst Jason Butler maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Market Outperform and lowers the price target from $50 to $23.

Posted In: HOOK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist